A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

BI 3820768OngoingRecruitingPhase 1Open NCT07306559 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT07306559 · Trial Tracker · ComplyRx